Can we optimise doxorubicin treatment regimens for children with cancer? Pharmacokinetic simulations and a Delphi consensus procedure

BACKGROUND: Despite its cardiotoxicity doxorubicin is widely used for the treatment of paediatric malignancies. Current treatment regimens appear to be suboptimal as treatment strategies vary and do not follow a clear pharmacological rationale. Standardisation of dosing strategies in particular for...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:BMC Pharmacol Toxicol
Hoofdauteurs: Siebel, Christian, Würthwein, Gudrun, Lanvers-Kaminsky, Claudia, André, Nicolas, Berthold, Frank, Castelli, Ilaria, Chastagner, Pascal, Doz, François, English, Martin, Escherich, Gabriele, Frühwald, Michael C., Graf, Norbert, Groll, Andreas H., Ruggiero, Antonio, Hempel, Georg, Boos, Joachim
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2020
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7254632/
https://ncbi.nlm.nih.gov/pubmed/32466789
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40360-020-00417-2
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items